Approval · Notice of Compliance 4092 · 1997
ZERIT: Notice of Compliance 4092
Issued December 15, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4092
- Date
- December 15, 1997
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for new dosage form and new pediatric indication
- Therapeutic class
- Antiretroviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZERIT | 02237009 | Cancelled Pre Market |
Medicinal ingredients
- STAVUDINE 1 MG per ML